The FTO A/T Polymorphism and Elite Athletic Performance: A Study Involving Three Groups of European Athletesстатья
Статья опубликована в высокорейтинговом журнале
Информация о цитировании статьи получена из
Web of Science,
Scopus
Статья опубликована в журнале из списка Web of Science и/или Scopus
Дата последнего поиска статьи во внешних источниках: 14 сентября 2013 г.
Аннотация:Objective: The FTO A/T polymorphism (rs9939609) is a strong candidate to influence obesity-related traits. Elite athletes
from many different sporting disciplines are characterized by low body fat. Therefore, the aim of this study was to assess
whether athletic status is associated with the FTO A/T polymorphism.
Subjects and Methods: A large cohort of European Caucasians from Poland, Russia and Spain were tested to examine the
association between FTO A/T polymorphism (rs9939609) and athletic status. A total of 551 athletes were divided by type of
sport (endurance athletes, n = 266 vs. sprint/power athletes, n = 285) as well as by level of competition (elite-level vs.
national-level). The control group consisted of 1,416 ethnically-matched, non-athletic participants, all Europeans.
Multinomial logistic regression analyses were conducted to assess the association between FTO A/T genotypes and
athletic status/competition level.
Results: There were no significantly greater/lesser odds of harbouring any type of genotype when comparing across athletic
status (endurance athletes, sprint/power athletes or control participants). These effects were observed after controlling for
sex and nationality. Furthermore, no significantly greater/lesser odds ratios were observed for any of the genotypes in
respect to the level of competition (elite-level vs. national-level).
Conclusion: The FTO A/T polymorphism is not associated with elite athletic status in the largest group of elite athletes
studied to date. Large collaborations and data sharing between researchers, as presented here, are strongly recommended
to enhance the research in the field of exercise genomics.